PLoS ONE (Jan 2020)

Prevalences of hyperuricemia and electrolyte abnormalities in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB).

  • Tadashi Sofue,
  • Naoki Nakagawa,
  • Eiichiro Kanda,
  • Hajime Nagasu,
  • Kunihiro Matsushita,
  • Masaomi Nangaku,
  • Shoichi Maruyama,
  • Takashi Wada,
  • Yoshio Terada,
  • Kunihiro Yamagata,
  • Ichiei Narita,
  • Motoko Yanagita,
  • Hitoshi Sugiyama,
  • Takashi Shigematsu,
  • Takafumi Ito,
  • Kouichi Tamura,
  • Yoshitaka Isaka,
  • Hirokazu Okada,
  • Kazuhiko Tsuruya,
  • Hitoshi Yokoyama,
  • Naoki Nakashima,
  • Hiromi Kataoka,
  • Kazuhiko Ohe,
  • Mihoko Okada,
  • Naoki Kashihara

DOI
https://doi.org/10.1371/journal.pone.0240402
Journal volume & issue
Vol. 15, no. 10
p. e0240402

Abstract

Read online

BackgroundThe Japan Chronic Kidney Disease Database (J-CKD-DB) is a nationwide clinical database of patients with chronic kidney disease (CKD) based on electronic health records. The objective of this study was to assess the prevalences of hyperuricemia and electrolyte abnormalities in Japanese patients with CKD.MethodsIn total, 35,508 adult outpatients with estimated glomerular filtration rates of 5-60 ml/min/1.73 m2 in seven university hospitals were included this analysis. The proportions of patients with CKD stages G3b, G4, and G5 were 23.5%, 7.6%, and 3.1%, respectively.ResultsLogistic regression analysis showed that prevalence of hyperuricemia was associated with CKD stages G3b (adjusted odds ratio [95% confidence interval]: 2.12 [1.90-2.37]), G4 (4.57 [3.92-5.32]), and G5 (2.25 [1.80-2.80]). The respective prevalences of hyponatremia, hypercalcemia, hyperphosphatemia, and narrower difference between serum sodium and chloride concentrations were elevated in patients with CKD stages G3b, G4, and G5, compared with those prevalences in patients with CKD stage G3a. The prevalences of hyperkalemia were 8.3% and 11.6% in patients with CKD stages G4 and G5, respectively. In patients with CKD stage G5, the proportions of patients with optimal ranges of serum uric acid, potassium, corrected calcium, and phosphate were 49.6%, 73.5%, 81.9%, and 56.1%, respectively.ConclusionsWe determined the prevalences of hyperuricemia and electrolyte abnormalities in Japanese patients with CKD using data from a nationwide cohort study.